Anatomic distribution of [18F] fluorodeoxyglucose-avid lymph nodes in patients with cervical cancer

Practical Radiation Oncology

Volumn 3, Issue 1, 2013, Pages 45-53

  Fontanilla, Hiral P ^a   Klopp, Ann H ^a   Lindberg, Mary E ^a   Jhingran, Anuja ^a   Kelly, Patrick ^a   Takiar, Vinita ^a   Iyer, Revathy B ^a   Levenback, Charles F ^a   Zhang, Yongbin ^a   Dong, Lei ^a   Eifel, Patricia J ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER LOCALIZATION; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; IMAGE ANALYSIS; LYMPH NODE METASTASIS; PATHOLOGICAL ANATOMY; PATIENT ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA;

EID: 84872041998     PISSN: 18798500     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prro.2012.02.003     Document Type: Article

References (29)

1. Eifel P.J., Winter K., Morris M., et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of Radiation Therapy Oncology Group trial (RTOG) 90-01. J Clin Oncol 2004, 22:872-880.
2. Landoni F., Maneo A., Colombo A., et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 1997, 350:535-540.
3. Beadle B.M., Jhingran A., Yom S.S., Ramirez P.T., Eifel P.J. Patterns of regional recurrence after definitive radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 2010, 76:1396-1403.
4. Mell L.K., Tiryaki H., Ahn K.H., Mundt A.J., Roeske J.C., Aydogan B. Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer. Int J Radiat Oncol Biol Phys 2008, 71:1504-1510.
5. Roeske J.C., Lujan A., Rotmensch J., Waggoner S.E., Yamada D., Mundt A.J. Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies. Int J Radiat Oncol Biol Phys 2000, 48:1613-1621.
6. Portelance L., Chao K.S., Grigsby P.W., Bennet H., Low D. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys 2001, 51:261-266.
7. Benedetti-Panici P., Maneschi F., Scambia G., et al. Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy. Gynecol Oncol 1996, 62:19-24.
8. Marnitz S., Köhler C., Bongardt S., et al. Topographic distribution of sentinel lymph nodes in patients with cervical cancer. Gynecol Oncol 2006, 103:35-44.
9. Dinniwell R., Chan P., Czarnota G., et al. Pelvic lymph node topography for radiotherapy treatment planning from ferumoxtran-10 contrast-enhanced magnetic resonance imaging. Int J Radiat Oncol Biol Phys 2009, 74:844-851.
10. Taylor A., Rockall A.G., Reznek R.H., Powell M.E. Mapping pelvic lymph nodes: guidelines for delineation in intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2005, 63:1604-1612.
11. Plentl A.A., Friedman E.A. Lymphatic system of the female genitalia. The morphologic basis of oncologic diagnosis and therapy. Major Probl Obstet Gynecol 1971, 2:1-223.
12. Mangan C.E., Rubin S.C., Rabin D.S., Mikuta J.J. Lymph node nomenclature in gynecologic oncology. Gynecol Oncol 1986, 23:222-226.
13. Choi H.J., Ju W., Myung S.K., Kim Y. Diagnostic performance of computer tomography, magnetic resonance imaging, and positron emission tomography or positron emission tomography/computer tomography for detection of metastatic lymph nodes in patients with cervical cancer: meta-analysis. Cancer Sci 2010, 101:1471-1479.
14. Grigsby P.W., Siegel B.A., Dehdashti F. Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol 2001, 19:3745-3749.
15. Small W.J., Mundt A.J. Consensus guidelines for the delineation of the intensity modulated pelvic radiotherapy CTV in the postoperative treatment of endometrial and cervical cancer Available at, Accessed March 1, 2011. http://www.rtog.org/CoreLab/ContouringAtlases/GYN.aspx.
16. Small W.J., Mell L.K., Anderson P., et al. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer. Int J Radiat Oncol Biol Phys 2008, 71:428-434.
17. Lim K., Small W., Portelance L., et al. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer. Int J Radiat Oncol Biol Phys 2011, 79:348-355.
18. Wang H., Dong L., O'Daniel J., et al. Validation of an accelerated 'demons' algorithm for deformable image registration in radiation therapy. Phys Med Biol 2005, 50:2887-2905.
19. McMahon C.J., Rofsky N.M., Pedrosa I. Lymphatic metastases from pelvic tumors: anatomic classification, characterization, and staging. Radiology 2010, 254:31-46.
20. Small W., Mell L.K., Anderson P., et al. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer. Int J Radiat Oncol Biol Phys 2008, 71:428-434.
21. Levenback C., Coleman R.L., Burke T.W., et al. Lymphatic mapping and sentinel node identification in patients with cervix cancer undergoing radical hysterectomy and pelvic lymphadenectomy. JClin Oncol 2002, 20:688-693.
22. Narayan K., Hicks R.J., Jobling T., Bernshaw D., McKenzie A.F. A comparison of MRI and PET scanning in surgically staged loco-regionally advanced cervical cancer: potential impact on treatment. Int J Gynecol Cancer 2001, 11:263-271.
23. Reinhardt M.J., Ehritt-Braun C., Vogelgesang D., et al. Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET. Radiology 2001, 218:776-782.
24. Ma S.Y., See L.C., Lai C.H., et al. Delayed (18)F-FDG PET for detection of paraaortic lymph node metastases in cervical cancer patients. J Nucl Med 2003, 44:1775-1783.
25. Roh J.W., Seo S.S., Lee S., et al. Role of positron emission tomography in pretreatment lymph node staging of uterine cervical cancer: a prospective surgicopathologic correlation study. Eur J Cancer 2005, 41:2086-2092.
26. Park W., Park Y.J., Huh S.J., et al. The usefulness of MRI and PET imaging for the detection of parametrial involvement and lymph node metastasis in patients with cervical cancer. Jpn J Clin Oncol 2005, 35:260-264.
27. Wright J.D., Dehdashti F., Herzog T.J., et al. Preoperative lymph node staging of early-stage cervical carcinoma by [18F]-fluoro-2-deoxy-D-glucose-positron emission tomography. Cancer 2005, 104:2484-2491.
28. Choi H.J., Roh J.W., Seo S.S., et al. Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinoma: a prospective study. Cancer 2006, 106:914-922.
29. Loft A., Berthelsen A.K., Roed H., et al. The diagnostic value of PET/CT scanning in patients with cervical cancer: a prospective study. Gynecol Oncol 2007, 106:29-34.